NYBC Ventures

Venture Capital

NYBC Ventures is a Venture Capital firm based in Boston, United States.

Early-stage life sciences VC fund accelerating breakthroughs in blood, cellular therapies, hematology, transfusion medicine, and infectious disease.

Early Stage
Cell Therapy
Hematology
Infectious Disease
Transfusion Medicine
Website
Headquarters
Boston, United States
Founded
2021
AUM
$50.0M
Portfolio Companies
3
Recorded investments
3
Latest recorded investment
Dec 2025
Geographic Focus
United States
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/nybc-ventures?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 3 portfolio companies and 3 funding rounds for this investor. to use credits for reveals, or explore the API.

Investment Thesis

Elevates investment performance leveraging New York Blood Center’s expertise in blood and cellular therapies to support visionary founders.

It was founded in 2021. Indexed has recorded 3 investments for NYBC Ventures. Its portfolio includes Cellular Origins, Avencell and Veralox Therapeutics. Focus areas include Cell Therapy and Hematology.

Portfolio3

Co-investors17

Sign up to view co-investors

Up to 24 co-investors shown

Venture Capital ×15 · Growth Equity ×1 · Corporate VC ×1

Recorded investments3

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

NYBC Ventures on Indexed.vc
<a href="https://indexed.vc/investors/nybc-ventures"><img src="https://indexed.vc/api/badge/investor/nybc-ventures" alt="NYBC Ventures on Indexed.vc" width="260" height="76" /></a>